PH13325A - Prostaglandin intermediates - Google Patents

Prostaglandin intermediates

Info

Publication number
PH13325A
PH13325A PH17409A PH17409A PH13325A PH 13325 A PH13325 A PH 13325A PH 17409 A PH17409 A PH 17409A PH 17409 A PH17409 A PH 17409A PH 13325 A PH13325 A PH 13325A
Authority
PH
Philippines
Prior art keywords
prostaglandin intermediates
prostaglandin
intermediates
Prior art date
Application number
PH17409A
Inventor
J Bindra
M Johnson
Original Assignee
Pfizer
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Pfizer filed Critical Pfizer
Publication of PH13325A publication Critical patent/PH13325A/en

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D257/00—Heterocyclic compounds containing rings having four nitrogen atoms as the only ring hetero atoms
    • C07D257/02—Heterocyclic compounds containing rings having four nitrogen atoms as the only ring hetero atoms not condensed with other rings
    • C07D257/04—Five-membered rings
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C405/00—Compounds containing a five-membered ring having two side-chains in ortho position to each other, and having oxygen atoms directly attached to the ring in ortho position to one of the side-chains, one side-chain containing, not directly attached to the ring, a carbon atom having three bonds to hetero atoms with at the most one bond to halogen, and the other side-chain having oxygen atoms attached in gamma-position to the ring, e.g. prostaglandins ; Analogues or derivatives thereof
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C405/00—Compounds containing a five-membered ring having two side-chains in ortho position to each other, and having oxygen atoms directly attached to the ring in ortho position to one of the side-chains, one side-chain containing, not directly attached to the ring, a carbon atom having three bonds to hetero atoms with at the most one bond to halogen, and the other side-chain having oxygen atoms attached in gamma-position to the ring, e.g. prostaglandins ; Analogues or derivatives thereof
    • C07C405/0008—Analogues having the carboxyl group in the side-chains replaced by other functional groups
    • C07C405/0041—Analogues having the carboxyl group in the side-chains replaced by other functional groups containing nitrogen
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D307/00—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom
    • C07D307/77—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom ortho- or peri-condensed with carbocyclic rings or ring systems
    • C07D307/93—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom ortho- or peri-condensed with carbocyclic rings or ring systems condensed with a ring other than six-membered
    • C07D307/935—Not further condensed cyclopenta [b] furans or hydrogenated cyclopenta [b] furans
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D309/00—Heterocyclic compounds containing six-membered rings having one oxygen atom as the only ring hetero atom, not condensed with other rings
    • C07D309/02—Heterocyclic compounds containing six-membered rings having one oxygen atom as the only ring hetero atom, not condensed with other rings having no double bonds between ring members or between ring members and non-ring members
    • C07D309/08—Heterocyclic compounds containing six-membered rings having one oxygen atom as the only ring hetero atom, not condensed with other rings having no double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D309/10—Oxygen atoms
    • C07D309/12—Oxygen atoms only hydrogen atoms and one oxygen atom directly attached to ring carbon atoms, e.g. tetrahydropyranyl ethers
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D405/00—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
    • C07D405/02—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings
    • C07D405/12—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings linked by a chain containing hetero atoms as chain links
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07F—ACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
    • C07F9/00—Compounds containing elements of Groups 5 or 15 of the Periodic Table
    • C07F9/02—Phosphorus compounds
    • C07F9/28—Phosphorus compounds with one or more P—C bonds
    • C07F9/38—Phosphonic acids [RP(=O)(OH)2]; Thiophosphonic acids ; [RP(=X1)(X2H)2(X1, X2 are each independently O, S or Se)]
    • C07F9/40—Esters thereof
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07F—ACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
    • C07F9/00—Compounds containing elements of Groups 5 or 15 of the Periodic Table
    • C07F9/02—Phosphorus compounds
    • C07F9/28—Phosphorus compounds with one or more P—C bonds
    • C07F9/38—Phosphonic acids [RP(=O)(OH)2]; Thiophosphonic acids ; [RP(=X1)(X2H)2(X1, X2 are each independently O, S or Se)]
    • C07F9/40—Esters thereof
    • C07F9/4003—Esters thereof the acid moiety containing a substituent or a structure which is considered as characteristic
    • C07F9/4006—Esters of acyclic acids which can have further substituents on alkyl
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07F—ACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
    • C07F9/00—Compounds containing elements of Groups 5 or 15 of the Periodic Table
    • C07F9/02—Phosphorus compounds
    • C07F9/28—Phosphorus compounds with one or more P—C bonds
    • C07F9/54—Quaternary phosphonium compounds
    • C07F9/5407—Acyclic saturated phosphonium compounds
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07F—ACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
    • C07F9/00—Compounds containing elements of Groups 5 or 15 of the Periodic Table
    • C07F9/02—Phosphorus compounds
    • C07F9/547—Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom
    • C07F9/6524—Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom having four or more nitrogen atoms as the only ring hetero atoms

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Biochemistry (AREA)
  • Molecular Biology (AREA)
  • Veterinary Medicine (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Animal Behavior & Ethology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Chemical & Material Sciences (AREA)
  • Public Health (AREA)
  • Engineering & Computer Science (AREA)
  • Medicinal Chemistry (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Furan Compounds (AREA)
  • Pyrane Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
PH17409A 1972-11-08 1975-07-24 Prostaglandin intermediates PH13325A (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US30481372A 1972-11-08 1972-11-08

Publications (1)

Publication Number Publication Date
PH13325A true PH13325A (en) 1980-03-13

Family

ID=23178133

Family Applications (3)

Application Number Title Priority Date Filing Date
PH15191A PH13272A (en) 1972-11-08 1973-11-07 Substituted w-pentanorprostaglandins
PH17410A PH13110A (en) 1972-11-08 1975-07-24 Dialkylphosphonates
PH17409A PH13325A (en) 1972-11-08 1975-07-24 Prostaglandin intermediates

Family Applications Before (2)

Application Number Title Priority Date Filing Date
PH15191A PH13272A (en) 1972-11-08 1973-11-07 Substituted w-pentanorprostaglandins
PH17410A PH13110A (en) 1972-11-08 1975-07-24 Dialkylphosphonates

Country Status (29)

Country Link
JP (3) JPS5416491B2 (en)
AR (3) AR200585A1 (en)
AT (3) AT367034B (en)
AU (1) AU470375B2 (en)
BE (1) BE806995A (en)
CA (3) CA1085831A (en)
CH (1) CH597176A5 (en)
CS (3) CS182791B2 (en)
DD (4) DD118856A5 (en)
DE (1) DE2355540C2 (en)
DK (1) DK144247C (en)
ES (3) ES420325A1 (en)
FI (1) FI60389C (en)
FR (3) FR2205335B1 (en)
GB (3) GB1456512A (en)
HK (3) HK28079A (en)
HU (3) HU172703B (en)
IE (1) IE39537B1 (en)
IL (1) IL43589A (en)
IN (1) IN139384B (en)
KE (3) KE2930A (en)
MY (3) MY7900246A (en)
NL (1) NL164273C (en)
NO (3) NO147836C (en)
PH (3) PH13272A (en)
SE (4) SE448992B (en)
SU (4) SU584766A3 (en)
YU (3) YU39715B (en)
ZA (1) ZA738554B (en)

Families Citing this family (18)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3929862A (en) * 1974-01-08 1975-12-30 Upjohn Co Substituted tolylesters of PGF{HD 2{B {60
US3986764A (en) * 1975-03-31 1976-10-19 Gte Automatic Electric Laboratories Incorporated Panel for supporting a pair of elongated mating connectors and selectively locking them together
GB1506817A (en) * 1975-03-31 1978-04-12 Upjohn Co Prostaglandins
ES449162A1 (en) * 1975-06-23 1977-12-16 Syntex Inc A PROCEDURE FOR THE PREPARATION OF A RACEMI-CO U 8R-ANTIMERIC COMPOUND.
GB1516414A (en) * 1975-08-22 1978-07-05 Ici Ltd Prostane derivatives
SE7809008L (en) * 1977-12-12 1979-06-13 Upjohn Co USE OF PROSTAGLAND TYPE AMIDES TO CONTROL OR REGULATE THE REPRODUCTION CYCLE IN INDIVIDUALS OF MAMMALS
IN150279B (en) * 1978-01-16 1982-09-04 Pfizer
SK3382000A3 (en) * 1997-09-09 2000-10-09 Procter & Gamble A compound having structure of aromatic substituted prostaglandins and its use for the treatment of bone disorders
CA2364948C (en) 1999-03-05 2011-04-26 Duke University C16 unsaturated fp-selective prostaglandins analogs
US6894175B1 (en) 1999-08-04 2005-05-17 The Procter & Gamble Company 2-Decarboxy-2-phosphinico prostaglandin derivatives and methods for their preparation and use
US20020013294A1 (en) 2000-03-31 2002-01-31 Delong Mitchell Anthony Cosmetic and pharmaceutical compositions and methods using 2-decarboxy-2-phosphinico derivatives
US20020172693A1 (en) 2000-03-31 2002-11-21 Delong Michell Anthony Compositions and methods for treating hair loss using non-naturally occurring prostaglandins
US20020037914A1 (en) 2000-03-31 2002-03-28 Delong Mitchell Anthony Compositions and methods for treating hair loss using C16-C20 aromatic tetrahydro prostaglandins
JP2002329615A (en) * 2001-05-02 2002-11-15 Ohira Denshi Kk Toroidal coil
US6476064B1 (en) * 2001-06-13 2002-11-05 Allergan, Inc. Cyclopentane heptan(ene) acyl sulfonamide, 2-alkyl or 2-arylalkyl, or 2-heteroarylalkenyl derivatives as therapeutic agents
US20060135609A1 (en) 2004-10-21 2006-06-22 Duke University Ophthamological drugs
US8722739B2 (en) 2008-10-29 2014-05-13 Novaer Holdings, Inc. Amino acid salts of prostaglandins
US8623918B2 (en) 2008-10-29 2014-01-07 Novaer Holdings, Inc. Amino acid salts of prostaglandins

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB1324737A (en) * 1970-11-02 1973-07-25 Upjohn Co Prostaglandins and the preparation thereof
IE37602B1 (en) * 1971-05-11 1977-08-31 Ici Ltd Cyclopentane derivatives

Also Published As

Publication number Publication date
CA1088930A (en) 1980-11-04
DE2355540A1 (en) 1974-05-22
YU270780A (en) 1982-06-18
YU39715B (en) 1985-04-30
NO148998B (en) 1983-10-17
CS182794B2 (en) 1978-05-31
IL43589A0 (en) 1974-03-14
FR2279729A1 (en) 1976-02-20
KE2931A (en) 1979-03-30
AR200585A1 (en) 1974-11-22
FR2205335B1 (en) 1978-07-13
HU171819B (en) 1978-03-28
HU172703B (en) 1978-11-28
AT367034B (en) 1982-05-25
SE448992B (en) 1987-03-30
GB1456514A (en) 1976-11-24
SE7700717L (en) 1977-01-24
SU745362A3 (en) 1980-06-30
KE2930A (en) 1979-03-30
PH13110A (en) 1979-11-28
SE445111B (en) 1986-06-02
JPS5257147A (en) 1977-05-11
DK144247B (en) 1982-01-25
FR2283146A1 (en) 1976-03-26
DE2365322B2 (en) 1977-02-24
MY7900245A (en) 1979-12-31
DD109212A5 (en) 1974-10-20
NO149139C (en) 1984-02-29
SU893130A3 (en) 1981-12-23
ES433046A1 (en) 1977-06-16
AR199966A1 (en) 1974-10-08
SE431756B (en) 1984-02-27
HK27979A (en) 1979-05-11
NL7315263A (en) 1974-05-10
YU36975B (en) 1984-08-31
NL164273C (en) 1980-12-15
JPS5253841A (en) 1977-04-30
SE7700718L (en) 1977-01-24
NO750535L (en) 1974-05-09
NO147836C (en) 1983-06-22
SU584766A3 (en) 1977-12-15
FI60389C (en) 1982-01-11
NO148998C (en) 1984-01-25
SE7700716L (en) 1977-01-24
DE2355540C2 (en) 1982-11-18
AR202931A1 (en) 1975-07-31
DD118856A5 (en) 1976-03-20
IN139384B (en) 1976-06-12
AU470375B2 (en) 1976-03-11
NO743493L (en) 1974-05-09
YU37316B (en) 1984-08-31
DK144247C (en) 1982-07-12
SU667141A3 (en) 1979-06-05
AT353285B (en) 1979-11-12
IE39537L (en) 1974-05-08
MY7900243A (en) 1979-12-31
ES433047A1 (en) 1976-11-01
AT360672B (en) 1981-01-26
GB1456512A (en) 1976-11-24
HK28179A (en) 1979-05-11
ATA544676A (en) 1979-04-15
CS182791B2 (en) 1978-05-31
KE2932A (en) 1979-03-30
NO147836B (en) 1983-03-14
FI60389B (en) 1981-09-30
IE39537B1 (en) 1978-11-08
PH13272A (en) 1980-02-27
JPS5416491B2 (en) 1979-06-22
AU6224773A (en) 1975-05-08
HK28079A (en) 1979-05-11
CA1088931A (en) 1980-11-04
BE806995A (en) 1974-05-07
CH597176A5 (en) 1978-03-31
FR2205335A1 (en) 1974-05-31
IL43589A (en) 1980-01-31
ATA544576A (en) 1980-06-15
DD117233A5 (en) 1976-01-05
JPS4993342A (en) 1974-09-05
NO149139B (en) 1983-11-14
FR2279729B1 (en) 1978-04-28
SE436278B (en) 1984-11-26
HU173507B (en) 1979-05-28
ES420325A1 (en) 1976-04-16
YU288073A (en) 1982-02-28
ZA738554B (en) 1974-09-25
GB1456513A (en) 1976-11-24
YU270680A (en) 1983-04-27
ATA936973A (en) 1981-10-15
MY7900246A (en) 1979-12-31
CS182793B2 (en) 1978-05-31
CA1085831A (en) 1980-09-16
DE2365322A1 (en) 1974-11-07
DD119411A5 (en) 1976-04-20
FR2283146B1 (en) 1981-06-19

Similar Documents

Publication Publication Date Title
HK14279A (en) Prostaglandin analogues
IL40801A0 (en) Novel substituted ceph-3-ems
PH12257A (en) New pyrazilodiazepine compounds
IL50968A0 (en) New substituted 2-benzoyl-benzoic acids
ZA732244B (en) Prostaglandin analogs
GB1403502A (en) Prostaglandin intermediates
PH10325A (en) Synthesis or zearalanes ii intermediates
AU469908B2 (en) Prostaglandin analogs
ZA73137B (en) Novel benzylpyrimidines
MY7700075A (en) Difluoromethylene substituted prostaglandin derivatives
IL42293A0 (en) Novel triazino-benzimidazoles
AU6322173A (en) Prostaglandin compositions
AU6034273A (en) Prostaglandin compounds
IE37498L (en) Prostaglandin intermediates
ZA732245B (en) Resolution of prostaglindin intermediates
CA892617A (en) Prostaglandin intermediates
GB1540427A (en) Prostaglandin analogues
CA895315A (en) Decarbamoylmitosane intermediates
ZA735739B (en) Prostaglandin analogs
IE38677L (en) Prostaglandin derivatives
CA984391A (en) Prostaglandin intermediates
IE38621L (en) Substituted 2-benzoyl-benzoic acids, intermediates
AU489464B2 (en) Prostenoic acid intermediates
ZA739176B (en) Prostaglandin compositions
ZA739715B (en) Prostaglandin analogues